Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 218

Results For "IMI"

4142 News Found

Dr. Reddy's Laboratories Q1 FY2024 consolidated PAT jumps to Rs. 1402.5 Cr
News | July 28, 2023

Dr. Reddy's Laboratories Q1 FY2024 consolidated PAT jumps to Rs. 1402.5 Cr

The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023


Astec LifeSciences posts consolidated Q1FY24 loss at Rs. 8.19 Cr
News | July 28, 2023

Astec LifeSciences posts consolidated Q1FY24 loss at Rs. 8.19 Cr

Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023


Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
News | July 28, 2023

Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr

The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023


Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr
News | July 28, 2023

Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr

The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023


Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer
News | July 28, 2023

Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer

Marks the World Head & Neck Cancer Day at the OCTF Conference


GenWorks introduces mechanical hysteroscopic tissue removal system
News | July 28, 2023

GenWorks introduces mechanical hysteroscopic tissue removal system

Uses a simple mechanical approach for removing intrauterine tissues


Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr
News | July 27, 2023

Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr

Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023


Eugia Pharma receives USFDA approval for Plerixafor Injection
Drug Approval | July 26, 2023

Eugia Pharma receives USFDA approval for Plerixafor Injection

The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023


TransCure bioServices partners with Preclina to expands reach into APAC
Biotech | July 26, 2023

TransCure bioServices partners with Preclina to expands reach into APAC

Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders